bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.07.26.550679

Reliability and generalizability of neural speech tracking in younger and older adults

Panela, R. A.·Copelli, F.·Herrmann, B.
View original source ↗Export metadata ↓

Abstract

Neural tracking of continuous, spoken speech is increasingly used to examine how the brain encodes speech and is considered a potential clinical biomarker, for example, for age-related hearing loss. A biomarker must be reliable (intra-class correlation [ICC] >0.7), but the reliability of neural-speech tracking is unclear. In the current study, younger and older adults (different genders) listened to stories in two separate sessions while electroencephalography (EEG) was recorded in order to investigate the reliability and generalizability of neural speech tracking. Neural speech tracking was larger for older compared to younger adults for stories under clear and background noise conditions, consistent with a loss of inhibition in the aged auditory system. For both age groups, reliability for neural speech tracking was lower than the reliability of neural responses to noise bursts (ICC >0.8), which we used as a benchmark for maximum reliability. The reliability of neural speech tracking was moderate (ICC [~]0.5-0.75) but tended to be lower for younger adults when speech was presented in noise. Neural speech tracking also generalized moderately across different stories (ICC [~]0.5-0.6), which appeared greatest for audiobook-like stories spoken by the same person. This indicates that a variety of stories could possibly be used for clinical assessments. Overall, the current data provide results critical for the development of a biomarker of speech processing, but also suggest that further work is needed to increase the reliability of the neural-tracking response to meet clinical standards. Significance statementNeural speech tracking approaches are increasingly used in research and considered a biomarker for impaired speech processing. A biomarker needs to be reliable, but the reliability of neural speech tracking is unclear. The current study shows in younger and older adults that the neural-tracking response is moderately reliable (ICC [~]0.5-0.75), although more variable in younger adults, and that the tracking response also moderately generalize across different stories (ICC [~]0.5-0.6), especially for audiobook-like stories spoken by the same person. The current data provide results critical for the development of a biomarker of speech processing, but also suggest that further work is needed to increase the reliability of the neural-tracking response to meet clinical standards.

Source connections

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Panela, R. A., Copelli, F., Herrmann, B.. 2023-07-28. Reliability and generalizability of neural speech tracking in younger and older adults. https://doi.org/10.1101/2023.07.26.550679

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗